Literature DB >> 21335447

The NICE Medical Technologies Advisory Committee and medical technologies guidance.

Bruce Campbell1.   

Abstract

Mesh：

Year:  2011        PMID： 21335447     DOI： 10.1136/hrt.2010.219741

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  3 in total

Review 1.  Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.

Authors:  Iain Willits; Helen Cole; Roseanne Jones; Kimberley Carter; Mick Arber; Michelle Jenks; Joyce Craig; Andrew Sims
Journal:  Appl Health Econ Health Policy       Date:  2017-08       Impact factor: 2.561

2.  Engaging with economic evaluation methods: insights from small and medium enterprises in the UK medical devices industry after training workshops.

Authors:  Michael P Craven; Matthew J Allsop; Stephen P Morgan; Jennifer L Martin
Journal:  Health Res Policy Syst       Date:  2012-09-03

Review 3.  Review of the role of NICE in promoting the adoption of innovative cardiac technologies.

Authors:  Peter H Groves; Chris Pomfrett; Mirella Marlow
Journal:  Heart       Date:  2018-05-17       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.